Skip to content

Meridian Bioscience Inc.

Active in EUDAMED

United Statesfrom SRN EUDAMED SRN US-MF-000044096

Meridian Bioscience Inc. is a medical device manufacturer based in the United States, with 246 devices listed in 4 registries (FDA Class I, II and III; EU Class A) and 22 FDA recalls as of 18 Nov 2026.

Devices
246
Registrations
EUDAMED
FDA recalls
229 ongoing

Registry facts

Counted by deviCERTS from registry records, 18 Nov 2026

Registries
  • FDA GUDID 207
  • FDA 510(k) 35
  • EUDAMED 30
  • FDA PMA 1

A device listed in two registries counts in both.

Device classes
  • FDA Class I 162
  • FDA Class II 62
  • EU Class A 16
  • FDA Class III 3
  • EU Class C 2
Sites and related companies
Identifiers
  • EUDAMED SRN US-MF-000044096
  • DUNS 092815364

At a glance

Counted by deviCERTS from registry records

Market reach

European Union
EUDAMED actor
United States
FDA recalls

What Meridian Bioscience Inc. makes

Meridian Bioscience Inc. manufactures in vitro diagnostic (IVD) kits and reagents for nucleic acid extraction and isolation, including DNA sample preparation systems and related consumables. Products include the M-prep DNA Sample Preparation Kit, Revogene Check assays, and Para-Pak series tubes, caps, and solvents designed for sample processing and purification.

These devices are classified as Class A under EU regulations and are listed in the EUDAMED database. The company is based in the United States.

AI-generated from registry data, 3 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue246

Newest first, rows 1-50 of 246

Search and filter all 246 devices
Skip device list

Rows 1-50 of 246

Showing 1-50 of 246

Company details

EUDAMED record synced 7 Nov 2026

EUDAMED SRN
US-MF-000044096
DUNS number
092815364
EUDAMED status
Active
EUDAMED registered name
Meridian Bioscience Inc.
EUDAMED abbreviated name
MBI Inc.
Registered address
3471, River Hills Drive, 45244, Cincinnati (OHIO), United States
Phone
+1 513.673.8109
PRRC contact
Susan Bogar(public in EUDAMED)

FDA recalls22

Recalls are matched to the firm by name. FDA recall data as of 1 Nov 2026.

Recalls initiated per year

  • 2017 0
  • 2018 1
  • 2019 0
  • 2020 0
  • 2021 3
  • 2022 3
  • 2023 3
  • 2024 0
  • 2025 3
  • 2026 0

9 initiated before 2017

Showing the 10 most recent of 22 recalls.

  • 2025

    • 5 Dec 2025 Z-1019-2026 Class II Ongoing The affected lots show a decline in performance over time, which may lead to false-negative results.via FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: US Nationwide distribution and the OUS country of Italy. Submission number: K172569
    • 7 Oct 2025 Z-0568-2026 Class II Ongoing The cap on the reaction buffer tube may be missing the black rubber gasket resulting in the potential for leakage and reduced buffer volume.via FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: US Distribution to states of: AL, CO, FL, GA, IL, MD, ME, MT, NH, NJ, OH, TN, TX and WA; and OUS (foreign) countries of:…
      Full distribution text US Distribution to states of: AL, CO, FL, GA, IL, MD, ME, MT, NH, NJ, OH, TN, TX and WA; and OUS (foreign) countries of: Canada, Italy, and Panama.
      Submission number: K110012
    • 7 Oct 2025 Z-0569-2026 Class II Ongoing The cap on the reaction buffer tube may be missing the black rubber gasket resulting in the potential for leakage and reduced buffer volume.via FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: US Distribution to states of: AL, CO, FL, GA, IL, MD, ME, MT, NH, NJ, OH, TN, TX and WA; and OUS (foreign) countries of:…
      Full distribution text US Distribution to states of: AL, CO, FL, GA, IL, MD, ME, MT, NH, NJ, OH, TN, TX and WA; and OUS (foreign) countries of: Canada, Italy, and Panama.
      Submission number: K121044
  • 2023

    • 19 Oct 2023 Z-0519-2024 Class II Ongoing Plastic vials contain a manufacturing defect may cause an increased risk of leakage and presents a risk of incidental exposure to biological hazards associated with direct contact with the patient specimen.via FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: Nationwide Foreign: Italy Submission number: K792710
    • 19 Oct 2023 Z-0520-2024 Class II Ongoing Plastic vials contain a manufacturing defect may cause an increased risk of leakage and presents a risk of incidental exposure to biological hazards associated with direct contact with the patient specimen.via FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: Nationwide Foreign: Italy Submission number: K792705
    • 19 Oct 2023 Z-0521-2024 Class II Ongoing Due to a manufacturing defect, certain Para-Pak vials may be at risk for leakage.via FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: Nationwide Foreign: Italy Submission number: K792710
  • 2022

    • 15 Dec 2022 Z-1008-2023 Class II Ongoing Leakage of the original specimen from the plastic microfluidic cartridge (PIE), possibility that laboratory personnel may be exposed to aerosolized specimen containing SARS-CoV-2via FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: US Nationwide distribution in the states of AZ, CA, IN, KS, KY, LA, MI, MN, NC, NY, OR, TX.
    • 22 Jun 2022 Z-1479-2022 Class II Ongoing When a run is aborted, the cooling period protection does not occur and the user is able to open the lid prior to the completion of the cooling period, exposing the user to heated instrument components. Incidental contact with heated instrument components may result in an injury such as minor burns.via FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: Worldwide distribution - US Nationwide and the countries of Australia, Chile, Italy, Qatar, and Switzerland. Submission number: K170558
    • 15 Feb 2022 Z-0836-2022 Class II Ongoing The photomultiplier tube, may have compromised functionality in some instruments. As a result, the user is likely to observe an increase in false-positive or indeterminate results.via FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: Worldwide distribution - US Nationwide distribution in the states of AK, AL, AR, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN,…
      Full distribution text Worldwide distribution - US Nationwide distribution in the states of AK, AL, AR, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, ME, MI, MN, MO, MS, MT, NC, NE, NJ, NV, NY, OH, OR, PA, PR, RI, SD, TN, TX, UT, VA, VT, WI, WV and the countries of Australia, Chile, Italy, Switzerland.
      Submission number: K170558
  • 2021

    • 8 Apr 2021 Z-1540-2021 Class II Terminated Emergency Use Application (EUA) application withdrawn as false negative results reportedvia FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: Nationwide
Show all 22 recalls
  • 2021

    • 8 Apr 2021 Z-1541-2021 Class II Terminated Emergency Use Application (EUA) application withdrawn as false negative results reportedvia FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: Nationwide
    • 8 Feb 2021 Z-1299-2021 Class II Terminated Use of the kits after incorrect storage could lead to a potential false-negative or invalid result. In the event of a false-negative, the incorrect assumption would be made as to the cause of patient symptoms. The appropriate treatment may not be administered, and symptoms may progress. Additional evaluations will be completed and documented within the associated Health Hazard Evaluation.via FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: US Nationwide distribution in the states of OH, SC. Submission number: K934550
  • 2018

    • 17 Dec 2018 Z-0732-2019 Class II Terminated An enzyme reagent included in the kit is not maintaining stability through claimed product expiration, resulting in the potential for false negative results when tested with patient specimens and the positive control.via FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: Worldwide Distribution - US Nationwide in the states of: AK, CA, CO, DE, IL, KS, KY, LA, MD, MO, NC, ND, NJ, NY, SC, TX,…
      Full distribution text Worldwide Distribution - US Nationwide in the states of: AK, CA, CO, DE, IL, KS, KY, LA, MD, MO, NC, ND, NJ, NY, SC, TX, and VA. The products were distributed to the following foreign countries: India and Italy.
      Submission number: K904393
  • 2016

    • 8 Nov 2016 Z-1033-2017 Class II Terminated Internal testing has demonstrated that the indicated kit lots produce false positive results when tested with some broth specimens.via FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: Product was shipped to the following states: AL. AZ, CA, CO, CT, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MO, MS,…
      Full distribution text Product was shipped to the following states: AL. AZ, CA, CO, CT, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MO, MS, MT, NC, NE, NJ, NV, NY, OH, OK, PA, SC, SD, TN, TX, UT, VA, VT, WA, WI & WY. Product was also sent to the following countries: CANADA, GERMANY, HONG KONG, ITALY, JAPAN & NEW ZEALAND.
      Submission number: K953362
  • 2014

    • 22 Apr 2014 Z-1941-2014 Class II Terminated Illumipro-10 instruments may have Block B chambers operating at an incorrect temperature as a result of incorrect temperature calibration.via FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: Worldwide Distribution - USA including AL, AZ, CA, CO, FL, IA, IN, LA, MA, ME, MI, MN, NJ, NY, OH, PA, and WV.…
      Full distribution text Worldwide Distribution - USA including AL, AZ, CA, CO, FL, IA, IN, LA, MA, ME, MI, MN, NJ, NY, OH, PA, and WV. Internationally to Australia.
      Submission number: K110012
  • 2011

    • 10 Oct 2011 Z-0203-2012 Unclassified (pre-2012) Terminated Internal testing has shown that the indicated kits produce false negative results when tested with some direct stool specimens. These false negative reactions are not observed for all devices tested, however, the rate of occurrence will likely impact clinical sensitivity as defined by product registration and associated instructions for use.via FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: Worldwide Distribution - USA including AL, AZ, CA, CO, CT, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, MI, MO, NC, NH, NJ,…
      Full distribution text Worldwide Distribution - USA including AL, AZ, CA, CO, CT, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, MI, MO, NC, NH, NJ, NY, OH, OK, PA, TN, TX, UT, VA, WA, WI and WV and the countries of AUSTRALIA, CANADA, CHILE, COSTA RICA, ITALY, JAPAN and NEW ZEALAND.
      Submission number: K953362
  • 2006

    • 2 Jun 2006 Z-1203-06 Unclassified (pre-2012) Terminated The product may produce non-specific reactions with negative specimens and/or the negative control reagent. These non-specific interactions may result in increased invalid test rates and/or positivity rates.via FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: Nationwide. Submission number: K041003
  • 2003

    • 23 Sep 2003 Z-0062-04 Unclassified (pre-2012) Terminated The kits were packaged with incorrect dispensing pipettes.via FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: The kits were shipped to consignees located nationwide, and into New Zealand, Haiti, Belgium, Italy, Brazil, Australia,…
      Full distribution text The kits were shipped to consignees located nationwide, and into New Zealand, Haiti, Belgium, Italy, Brazil, Australia, Canada, and Chile.
      Submission number: K993914
    • 18 Jun 2003 Z-1127-03 Unclassified (pre-2012) Terminated The Low Positive Standard kit component is losing potency that may result in false positive test results.via FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: The kits were shipped to end-users located in CA, UT, NY, MD, KY; and to a foreign distributor in Belgium. Submission number: K924096
  • 2002

    • 26 Dec 2002 Z-0463-03 Unclassified (pre-2012) Terminated Due to defective packaging, the firm cannot assure product stability through the labeled expiration date.via FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: The kits were distributed to end-users and distributors located nationwide; and to foreign distributors located in…
      Full distribution text The kits were distributed to end-users and distributors located nationwide; and to foreign distributors located in China, Guatemala, New Zealand, Hong Kong, Mexico, Great Britain, Belgium, Italy, Brazil, Australia, Canada, Thailand, Honduras, and Japan.
      Submission number: K926442
    • 26 Dec 2002 Z-0464-03 Unclassified (pre-2012) Terminated Due to defective packaging, the firm cannot assure product stability through the labeled expiration date.via FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: The kits were distributed to end-users and distributors located nationwide; and to foreign distributors located in…
      Full distribution text The kits were distributed to end-users and distributors located nationwide; and to foreign distributors located in China, Guatemala, New Zealand, Hong Kong, Mexico, Great Britain, Belgium, Italy, Brazil, Australia, Canada, Thailand, Honduras, and Japan.
      Submission number: K993914
    • 26 Dec 2002 Z-0465-03 Unclassified (pre-2012) Terminated Due to defective packaging, the firm cannot assure product stability through the labeled expiration date.via FDA establishment MERIDIAN BIOSCIENCE, INC. Distribution: The kits were distributed to end-users and distributors located nationwide; and to foreign distributors located in…
      Full distribution text The kits were distributed to end-users and distributors located nationwide; and to foreign distributors located in China, Guatemala, New Zealand, Hong Kong, Mexico, Great Britain, Belgium, Italy, Brazil, Australia, Canada, Thailand, Honduras, and Japan.
      Submission number: K983255

Sites1

From the company website

Read 1 Oct 2026

Life Discovered. Life Science Leading manufacturer of molecular and immunological reagents for diagnostic applications. Explore Life Science Life Diagnosed. Diagnostics Best-in-class diagnostic platforms, tests, education, and support to help you deliver answers. Explore Diagnostics Breaking News! Meridian Bioscience Wins the CDC’s Lead Detect Prize Competition, Building on Decades of Leadership in Blood Lead Testing at

From the manufacturer's own website. Source

Frequently asked questions

How many devices does Meridian Bioscience Inc. have in the registry?

The registry currently lists 246 devices for Meridian Bioscience Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Meridian Bioscience Inc.'s devices?

Among its 50 most recently registered devices, Meridian Bioscience Inc. has devices listed in EUDAMED (5 devices) and FDA GUDID (48 devices). A device can be listed in more than one registry, so these counts overlap.

What risk classes do Meridian Bioscience Inc.'s devices fall under?

Among its 50 most recently registered devices, the classes recorded for Meridian Bioscience Inc.'s devices are Class I, Class II, Class III and IVDR Class C. Each device page shows its own class and authorisation.

Are there FDA recall records for Meridian Bioscience Inc.?

FDA recall records list 22 recalls initiated by Meridian Bioscience Inc., the most recent initiated on 5 Dec 2025. 9 of them are recorded as ongoing. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.

What are the newest devices from Meridian Bioscience Inc. in the registry?

The most recently registered devices listed for Meridian Bioscience Inc. include Alethia Chlamydia, alethia® Gonorrhea, StatID PRO COVID/Flu A&B Swabs 783110 and statID Pro COVID-19/Flu External Controls 783010.

Generated automatically from registry data and not verified by a human reviewer.